Genome Therapeutics Inc., Versicor deal

GENE and Versicor agreed to research and develop new anti-bacterial compounds from which

Read the full 135 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE